These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 16799097

  • 1. Testosterone and doping control.
    Saudan C, Baume N, Robinson N, Avois L, Mangin P, Saugy M.
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [Abstract] [Full Text] [Related]

  • 2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F, Mazzucco E, Gennaro MC, Marengo E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May 15; 927():22-36. PubMed ID: 23317577
    [Abstract] [Full Text] [Related]

  • 3. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
    Cawley AT, Hine ER, Trout GJ, George AV, Kazlauskas R.
    Forensic Sci Int; 2004 Jul 16; 143(2-3):103-14. PubMed ID: 15240029
    [Abstract] [Full Text] [Related]

  • 4. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
    Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F.
    Clin Endocrinol (Oxf); 2011 Jul 16; 75(1):134-40. PubMed ID: 21521264
    [Abstract] [Full Text] [Related]

  • 5. A steroidomic approach for biomarkers discovery in doping control.
    Boccard J, Badoud F, Grata E, Ouertani S, Hanafi M, Mazerolles G, Lantéri P, Veuthey JL, Saugy M, Rudaz S.
    Forensic Sci Int; 2011 Dec 10; 213(1-3):85-94. PubMed ID: 21831550
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O, Lehmann S, Vollmer G, Schänzer W, Diel P.
    Steroids; 2008 Oct 10; 73(11):1143-7. PubMed ID: 18550137
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M, Geyer H, Mareck U, Flenker U, Schänzer W.
    Ther Drug Monit; 2007 Apr 10; 29(2):236-47. PubMed ID: 17417080
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P, Delbeke FT.
    J Steroid Biochem Mol Biol; 2006 Nov 10; 101(4-5):161-78. PubMed ID: 17000101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.